The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin

68Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE - To assess the absorption profile of inhaled insulin in healthy, actively smoking subjects at baseline, after smoking cessation, and after smoking resumption and compare it with nonsmoking subjects. RESEARCH DESIGN AND METHODS - Insulin pharmacokinetics and glucodynamics were measured in 20 male smoking subjects (10-20 cigarettes/day) and 10 matched non-smoking subjects after receiving inhaled insulin (1 mg) or the approximate subcutaneous insulin equivalent (3 units) in a randomized cross-over fashion. All smokers then received inhaled insulin 12 h, 3 days, and 7 days into a smoking cessation period. They then resumed smoking for 2-3 days before again receiving inhaled insulin 1 h after the last cigarette. RESULTS - Before smoking cessation, maximum insulin concentration (Cmax) and area under the curve (AUC) for insulin concentration time (AUC-Insulin0-360) with inhaled insulin were higher, and time to Cmax (tmax) shorter, in smokers than nonsmokers (Cmax 26.8 vs. 9.7 μU/ml; AUC-Insulin 0-360 2,583 vs. 1,645 μU·ml-1·min -1; tmax 20 vs. 53 min, respectively; all P < 0.05), whereas with subcutaneous insulin, systemic exposure was unchanged (AUC-Insulin0-360 2,324 vs. 2,269 μU ·ml -1·min-1; P = NS). After smoking cessation, AUC-Insulin0-360 decreased with inhaled insulin by up to 50% within 1 week and approached nonsmoker levels. Cmax decreased and t max increased relative to baseline but were still not comparable with nonsmoker values. Smoking resumption completely reversed the effect of smoking cessation. Glucodynamics corroborated the observed findings in insulin pharmacokinetics. CONCLUSIONS - Cessation and resumption of smoking greatly altered the pharmacokinetics of inhaled insulin. As rapid changes in systemic insulin exposure increase hypoglycemia risk, inhaled insulin should not be used in people with diabetes who choose to continue smoking. This is consistent with recommendations that people with diabetes refrain from smoking altogether. © 2006 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Becker, R. H. A., Sha, S., Frick, A. D., & Fountaine, R. J. (2006). The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care, 29(2), 277–282. https://doi.org/10.2337/diacare.29.02.06.dc05-1913

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free